Company / Interest Expense
Thermo Fisher Scientific Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$536.0M
FY2023
5-year range
$536.0M / $676.0M
FY2019-FY2023
Trend
-3.1%
vs FY2022
Sector context
#9 of 44
Health Care
What the data says
Thermo Fisher Scientific's interest expense of $536M is higher than 80% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 8 years, ranging from $469M in FY2016 to $676M in FY2021.
Based on SEC 10-K filings.
$536M in FY2023 with a 5-year CAGR of -4.3%. Top quartile in the Health Care sector.
Improved from $676M to $536M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 44This company $536.0M Sector average $316.9M
▼
+69.1% above sector average
Key checks
Key Insights
- 5-year CAGR of -4.3%, indicating a declining trend.
- In FY2023, interest expense decreased 3.1% year-over-year.
- Ranks #9 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $536.0M | -3.1% |
| FY2022 | $553.0M | -18.2% |
| FY2021 | $676.0M | +22.2% |
| FY2020 | $553.0M | -18.2% |
| FY2019 | $676.0M | +1.3% |
| FY2018 | $667.0M | +12.7% |
| FY2017 | $592.0M | +26.2% |
| FY2016 | $469.0M | +13.0% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026